JACC. Cardiovascular interventions
-
JACC Cardiovasc Interv · Nov 2010
Complications and outcome of balloon aortic valvuloplasty in high-risk or inoperable patients.
This study aimed to determine the success, complications, and survival of patients after balloon aortic valvuloplasty (BAV). ⋯ Long-term survival is poor after BAV alone. BAV as a bridge to percutaneous or surgical aortic valve replacement is feasible, safe, and associated with better outcome than BAV alone.
-
JACC Cardiovasc Interv · Nov 2010
Embolic cerebral insults after transapical aortic valve implantation detected by magnetic resonance imaging.
This study assessed the rate of periprocedural embolic ischemic brain injury during transapical aortic valve replacement in 25 consecutive patients. ⋯ New embolic ischemic cerebral insults are detected in 68% of patients after transapical valve implantation. Clinical symptoms are rare and usually transitory. Larger trials will need to establish the clinical significance of asymptomatic ischemic lesions as well as the rate of ischemic events in patients undergoing transfemoral valve replacement.
-
JACC Cardiovasc Interv · Nov 2010
ReviewThe global experience with percutaneous aortic valve replacement.
Transcatheter aortic valve replacement is now a viable option in the treatment of high-risk severe symptomatic aortic stenosis. This review describes the current data with this technology and also the potential for the future role of the technology, including potential ways to yet further improve the short- and longer-term results.
-
JACC Cardiovasc Interv · Nov 2010
Outcomes after transcatheter aortic valve implantation with both Edwards-SAPIEN and CoreValve devices in a single center: the Milan experience.
Our aim was to assess clinical outcome after transcatheter aortic valve implantation (TAVI) performed with the 2 commercially available valves with 3 delivery approaches selected in a stepwise fashion. ⋯ Routine TAVI using both MCV and ESV with a selection of approaches is feasible and allows treatment of a wide range of patients with good overall procedural success rates and 30-day and 6-month outcomes.